Atria Investments Inc Has $449,000 Holdings in Azenta, Inc. (NASDAQ:AZTA)

Atria Investments Inc cut its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 40.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 9,270 shares of the company’s stock after selling 6,291 shares during the quarter. Atria Investments Inc’s holdings in Azenta were worth $449,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. QRG Capital Management Inc. lifted its holdings in shares of Azenta by 6.6% during the 3rd quarter. QRG Capital Management Inc. now owns 6,156 shares of the company’s stock valued at $298,000 after buying an additional 383 shares during the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after buying an additional 256 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Azenta by 1.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 36,710 shares of the company’s stock valued at $1,778,000 after buying an additional 700 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock valued at $62,917,000 after buying an additional 183,040 shares during the last quarter. Finally, Net Worth Advisory Group acquired a new stake in shares of Azenta during the 3rd quarter valued at about $205,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on AZTA. Needham & Company LLC reduced their price target on Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Evercore ISI reduced their target price on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $63.60.

Azenta Stock Performance

AZTA opened at $44.65 on Thursday. The business has a 50 day moving average price of $45.32 and a 200 day moving average price of $50.22. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $69.16. The firm has a market cap of $2.18 billion, a P/E ratio of -15.03 and a beta of 1.48.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. The company had revenue of $170.00 million for the quarter, compared to the consensus estimate of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.13 EPS. As a group, analysts anticipate that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO John Marotta acquired 12,717 shares of the stock in a transaction dated Monday, November 18th. The shares were acquired at an average cost of $39.48 per share, for a total transaction of $502,067.16. Following the completion of the transaction, the chief executive officer now owns 99,612 shares in the company, valued at approximately $3,932,681.76. This trade represents a 14.63 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Herman Cueto sold 1,595 shares of the business’s stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total value of $69,669.60. Following the sale, the chief financial officer now owns 24,604 shares in the company, valued at approximately $1,074,702.72. This represents a 6.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.77% of the company’s stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.